NanoViricides Builds Plant to Prep for 'Viral Penicillin' Pipeline
NanoViricides has begun construction of a new GMP sterile manufacturing facility to support approaching human trials in its anti-viral drug pipeline.
Archives for August 20, 2013
CHO Know-How and Location Won Rentschler Contract says Apeiron
Mammalian cell culture know-how and location won Rentschler Biotechnologie its new anticancer MAb manufacturing deal according Austrian BioPharma Apeiron Biologics.
Bio Innovators Don't Need to Be Tech "Integrators" with HarvestClear says Parker
Parker Domnick Hunter has launched a new filtration tech for antibody makers that combines know-how from several firms acquired over the past few years.
Rise of Yeast-Based MAb Tech as Adimab Inks Two More Deals
Adimab says it is cornering the market with its yeast-based monoclonal antibody (MAb) technology after inking another two discovery collaborations.
More Manufacturing Issues Lead to Alexion Recall
Alexion Pharma International has recalled a single lot of its monoclonal antibody (MAb) orphan drug Soliris due to the presence of visible particles in a limited number of vials.